business

AstraZeneca Broadens US Growth Push

5 Haziran 2026Bloomberg

AstraZeneca CFO Aradhana Sarin discusses how the pharmaceutical company is broadening its US shareholder base and plans to generate $80 Billion in revenue by 2030. She speaks with Bloomberg's Katie Greifeld.
(Source: Bloomberg)
Published 10 minutes ago, this story falls under business coverage. Follow updates from Bloomberg for related developments.
This story was reported by Bloomberg. Key takeaways: • AstraZeneca CFO Aradhana Sarin discusses how the pharmaceutical company is broadening its US shareholder base and plans to generate $80 Billion in revenue by 2030.

NewsAI özeti

ℹ️ This article was automatically processed by NewsAI. A standard summary is shown while the AI service is temporarily unavailable.